Table 2 Number of confirmed selective serotonin reuptake inhibitor (SSRI) reports, number of SSRI prescriptions and the calculated reporting rates (number of confirmed SSRI reports/number of SSRI prescriptions) in the post-warning period from Germany
Number of confirmed reports from Germany in post-warning period (2009–2019) | Number of drug prescriptions in post-warning period (2009–2019) | Reporting rate per 100,000 drug prescriptions in post-warning period (2009–2019) | |
|---|---|---|---|
SSRI | 33 | 2,655,383 | 1.2 |
Female | 26 | 1,738,983 | 1.5 |
Male | 6 | 916,400 | 0.7 |
12–18 years | 18 | 751,875 | 2.4 |
19–24 years | 16 | 1,903,508 | 0.8 |
Citalopram | 8 | 831,482 | 1.0 |
Female | 7 | 541,856 | 1.3 |
Male | 1 | 289,626 | 0.3 |
12–18 years | 5 | 124,643 | 4.0 |
19–24 years | 3 | 706,839 | 0.4 |
Escitalopram | 8 | 461,845 | 1.7 |
Female | 7 | 300,504 | 2.3 |
Male | 1 | 161,341 | 0.6 |
12–18 years | 5 | 83,012 | 6.0 |
19–24 years | 3 | 378,833 | 0.8 |
Fluoxetine | 7 | 670,432 | 1.0 |
Female | 5 | 470,177 | 1.1 |
Male | 2 | 200,255 | 1.0 |
12–18 years | 6 | 366,579 | 1.6 |
19–24 years | 1 | 303,853 | 0.3 |
Sertraline | 9 | 443,490 | 2.0 |
Female | 7 | 284,752 | 2.5 |
Male | 2 | 158,738 | 1.3 |
12–18 years | 1 | 223,337 | 0.4 |
19–24 years | 8 | 343,207 | 2.3 |